Functionally distinct NKT cell subsets and subtypes

Journal of Experimental Medicine

Volumn 202, Issue 12, 2005, Pages 1623-1626

  Seino, Ken Ichiro ^a   Taniguchi, Masaru ^a  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; CELL ACTIVATION; CELL FUNCTION; CELL MATURATION; CELL SUBPOPULATION; CYTOKINE PRODUCTION; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNE SYSTEM; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR REJECTION;

GLYCOLIPIDS; IMMUNOTHERAPY; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; NEOPLASMS; ORGAN SPECIFICITY;

EID: 29144497339     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20051600     Document Type: Review

References (30)

1. + T cells. Curr. Opin. Immunol. 15:336-342.
2. Zhou, D., J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y.P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science. 306:1786-1789.
3. Taniguchi, M., M. Harada, S. Kojo, T. Nakayama, and H. Wakao. 2003. The regulatory role of Vα14NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21:483-513.
4. Godfrey, D.I., H.R. Macdonald, M. Kronenberg, M.J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4:231-237.
5. Jahng, A., I. Maricic, C. Aguilera, S. Cardell, R.C. Halder, and V. Kumar. 2004. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J. Exp. Med. 199:947-957.
6. Crowe, N.Y., J.M. Coquet, S.P. Berzins, K. Kyparissoudis, R. Keating, D.G. Pellicci, Y. Hayakawa, D.I. Godfrey, and M.J. Smyth. 2005. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202:1279-1288.
7. Terabe, M. 2005. A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J. Exp. Med. 202:1627-1633.
8. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187:1047-1056.
9. + T regulatory cells following antigen inoculation in an immune-privileged site. J. Immunol. 171:1266-1271.
10. Gumperz, J.E., S. Miyake, T. Yamamura, and M.B. Brenner. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195:625-636.
11. Lee, P.T., K. Benlagha, L. Teyton, and A. Bendelac. 2002. Distinct functional lineages of human Vα24 natural killer T cells. J. Exp. Med. 195:637-641.
12. Crowe, N.Y., M.J. Smyth, and D.I. Godfrey. 2002. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J. Exp. Med. 196:119-127.
13. + T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood. 99:1259-1266.
14. Terabe, M., S. Matsui, J.M. Park, M. Mamura, N. Noben-Trauth, D.D. Donaldson, W. Chen, S.M. Wahl, S. Ledbetter, B. Pratt, et al. 2003. Transforming growth factor-β production and myeloid cells are an effector mechanism through which CD1drestricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J. Exp. Med. 198:1741-1752.
15. Benlagha, K., D.G. Wei, J. Veiga, L. Teyton, and A. Bendelac. 2005. Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 202:485-492.
16. + cells originate from multiple pathways. J. Immunol. 162:3753-3756.
17. + NKT cells. J. Immunol. 162:5094-5098.
18. + NKT cells patrolling liver sinusoids. PLoS. Biol. 3:e113.
19. Matsumoto, G., E. Kubota, Y. Omi, U. Lee, and J.M. Penninger. 2004. Essential role of LFA-1 in activating Th2-like responses by α- galactosylceramide-activated NKT cells. J. Immunol. 173:4976-4984.
20. Johnston, B., C.H. Kim, D. Soler, M. Emoto, and E.C. Butcher. 2003. Differential chemokine responses and homing patterns of murine TCRαβ NKT cell subsets. J. Immunol. 171:2960-2969.
21. Yang, Y., A. Ueno, M. Bao, Z. Wang, J.S. Im, S. Porcelli, and J.W. Yoon. 2003. Control of NKT cell differentiation by tissue-specific microenvironments. J. Immunol. 171:5913-5920.
22. + NK T cells. J. Immunol. 158:2076-2082.
23. Miyamoto, K., S. Miyake, and T. Yamamura. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature. 413:531-534.
24. Schmieg, J., G. Yang, R.W. Franck, and M. Tsuji. 2003. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand α-galactosylceramide. J. Exp. Med. 198:1631-1641.
25. Mattner, J., K.L. Debord, N. Ismail, R.D. Goff, C. Cantu III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature. 434:525-529.
26. Kinjo, Y., D. Wu, G. Kim, G.W. Xing, M.A. Poles, D.D. Ho, M. Tsuji, K. Kawahara, C.H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature. 434: 520-525.
27. Kojo, S., K. Seino, M. Harada, H. Watarai, H. Wakao, T. Uchida, T. Nakayama, and M. Taniguchi. 2005. Induction of regulatory properties in dendritic cells by Vα14 NKT cells. J. Immunol. 175:3648-3655.
28. Fujii, S., K. Shimizu, C. Smith, L. Bonifaz, and R.M. Steinman. 2003. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198:267-279.
29. Starr, T.K., S.C. Jameson, and K.A. Hogquist. 2003. Positive and negative selection of T cells. Annu. Rev. Immunol. 21:139-176.
30. Hayakawa, Y., S.P. Berzins, N.Y. Crowe, D.I. Godfrey, and M.J. Smyth. 2004. Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors. Nat. Immunol. 5:590-596.